Obstructive Sleep Apnea, Preoperative Evaluation
Conditions
Keywords
preoperative, STOP-BANG score, Obstructive Sleep Apnea, AI, OSA
Brief summary
The goal of this observational study is to evaluate the feasibility of a systematic screening protocol for Obstructive Sleep Apnea (OSA) during preoperative anesthesia consultations in adults aged 50 and older undergoing elective surgery. The main questions it aims to answer are: * Does the systematic screening protocol increase the proportion of patients identified as being at high risk for OSA compared to standard care? * What is the impact of systematic screening on postoperative outcomes, including complications, length of stay, and mortality? Researchers will compare standard care practices (before implementation) to the systematic screening protocol (after implementation) to determine the effect on OSA detection rates and clinical outcomes. Participants will: * Complete the STOP-BANG questionnaire during their anesthesia consultation. * (Optional) Have a facial photograph taken to analyze morphometric characteristics that may correlate with OSA risk. * Be referred for further diagnostic testing if identified as high-risk for OSA.
Interventions
None listed
Sponsors
Department of Anesthesiology, Hopital Foch, Suresnes, France.
GCS Ramsay Santé pour l'Enseignement et la Recherche
Hôpital privé Claude Galien - Quincy-sous-Sénart
Intelligence Anesthesia
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All patients with a national health identifier affiliated with the social security system, aged over 18, including French individuals over 50 years old, in scheduled anesthesia consultation with STOP BANG \> 5 or \> 4 with BMI \> 35
Exclusion criteria
* Refusal to participate in the study, age under 50, not affiliated with the social security system, minor or under legal protection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| proportion of participants in whom the risk of OSA (Obstructive Sleep Apnea Syndrome) was detected in the control group before versus the group after | From enrollment to the end of treatment at 7 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative length of stay. | From enrollment to the end of treatment at 7 months | — |
| Sensitivity, specificity, and concordance rate of OSA (Obstructive Sleep Apnea Syndrome) detection. | From enrollment to the end of treatment at 7 months | — |
| Mortality at 3 months. | From enrollment to the end of treatment at 7 months | — |
| Postoperative complications and mortality at 3 months. | From enrollment to the end of treatment at 7 months | — |
| Postoperative complications | From enrollment to the end of treatment at 7 months | Pulmonary event Cardiac event Kidney event Vascular event |
| Correlation between facial morphotype and OSA diagnosis with and without facial morphotype measurement. | From enrollment to the end of treatment at 7 months | — |
Countries
France
Outcome results
None listed